Prev：Development of Daruharidra (Berberis aristata) Based Biogenic Cadmium Sulfide Nanoparticles: Their Implementation as Antibacterial and Novel Therapeutic Agents against Human Breast and Ovarian Cancer.(KTA0002-2)
Next：Development of miRNA-based PROTACs targeting Lin28 for breast cancer therapy(A25022-12.5)
